申请人:Bayer Aktiengesellschaft
公开号:US05514803A1
公开(公告)日:1996-05-07
The invention relates to new 2,6-disubstituted 4-quinolyl-dihydropyridines ##STR1## in which R.sub.1 to R.sub.5 have the meaning indicated in the description, processes for their preparation and their use in medicaments, in particular in compositions for the treatment of cardiovascular disorders.
本发明涉及新的2,6-二取代的4-喹啉基-二氢吡啶##STR1##其中R.sub.1至R.sub.5具有说明书中所示的含义,它们的制备过程以及它们在药物中的应用,特别是在治疗心血管疾病的组合物中的应用。